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Previous work has demonstrated that the bone morphogenetic proteins (BMP)-2, BMP-4, and BMP-7 can promote the
development of tyrosine hydroxylase (TH)-positive and catecholamine-positive cells in quail trunk neural crest cultures.
In the present work, we showed that mRNA for the type I bone morphogenetic protein receptor IA (BMPR-IA) was present
in neural crest cells grown in the absence or presence of BMP-4. We have used a replication-competent avian retrovirus
to express a constitutively active form of BMPR-IA in neural crest cells in culture. Cultures grown in the absence of BMP-
4 and infected with retrovirus containing a construct encoding this activated BMPR-IA developed ®ve times more TH-
immunoreactive and catecholamine-positive cells than uninfected control cultures or cultures infected with virus bearing
the wild-type BMPR-IA cDNA. The number of TH-positive cells which developed was dependent on the concentration of
virus bearing the activated receptor cDNA used in the experiments. Most TH-positive cells which developed also con-
tained viral p19 protein. Total cell number was not affected by infection with the virus containing the activated
receptor construct. The effect of the activated receptor was phenotype-speci®c since infection with the virus bearing the
activated receptor cDNA did not alter the number or morphology of microtubule-associated protein (MAP)2-immuno-
reactive cells, which are distinct from the TH-positive cell population. These ®ndings are consistent with the obser-
vation that MAP2-positive cells are not affected by the presence of BMP-4. Taken together, these results suggest that
activity of BMPR-IA is an important element in promoting the development of the adrenergic phenotype in neural crest
cultures. q 1998 Academic Press
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INTRODUCTION subsequently migrate along de®ned pathways to many sites
in the embryo. After they cease migration, neural crest cells
differentiate into a wide array of cell types including neu-The development of progenitor cells in the nervous sys-
rons and glia of the dorsal root; sympathetic, parasympa-tem is profoundly in¯uenced by a variety of extracellular
thetic, and enteric ganglia; melanocytes of the skin andsignals, including growth factors and extracellular matrix
irides; chromaf®n cells of the adrenal medulla; connectivemolecules. One vertebrate system that is particularly favor-
tissue cells of the head and face; and cells that make upable for the analysis of how such signals act to in¯uence
part of the aorticopulmonary septum of the heart (Hall anddevelopment is the embryonic neural crest (Anderson, 1993;
Horstadius, 1988; Kirby et al., 1983; LeDouarin, 1982; No-Bronner-Fraser, 1993; Marusich and Weston, 1991). Neural
den, 1978; Weston, 1970). Several lines of investigation indi-crest cells initially form from the dorsal neural tube and
cate that at least some neural crest cells are multipotential
with respect to their phenotypic fate (Bronner-Fraser and
Fraser, 1988; Barof®o et al., 1988; Frank and Sanes, 1991;1 To whom correspondence should be addressed. Fax: 860-679-
1274. E-mail: maxwell@neuron.uchc.edu. Sieber-Blum and Cohen, 1980; Sieber-Blum, 1991). Trans-
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plantation studies using avian embryos, as well as in vitro Experiments conducted with type I TGF-b receptors indi-
cate that mutant constitutively active forms of the typestudies, indicate that molecules in the embryonic environ-
ment encountered by neural crest cells during or after mi- I receptor can transmit signals leading to changes in cell
function which mimic the effect of ligand (Wieser et al.,gration are important determinants of cell fate and pheno-
type (LeDouarin, 1982; Noden, 1978; Stemple and Ander- 1995; Attisano et al., 1996; Hoodless et al., 1996). In the
case of TGF-b, these activated type I receptors can transduceson, 1993; Weston, 1970).
Among the molecules that have been identi®ed as being signal in the absence of both ligand and type II receptor
(Wieser et al., 1995). Recent work has shown that in theimportant in neural crest cell development are members of
the TGF-b superfamily of proteins (Howard and Gershon, developing limb constitutively active type I BMP receptors
can activate distinct cellular processes. The BMPR-IA regu-1993; Rogers et al., 1992; Zhang et al., 1997a; Jakowlew et
al., 1994, Leblanc et al., 1995). Within the TGF-b superfam- lates chondrocyte differentiation and is expressed in prehy-
pertrophic chondrocytes, while BMPR-IB plays a role inily the subfamily of the bone morphogenetic proteins
(BMPs) has attracted considerable attention. The BMPs play apoptosis and in de®ning the future cartilage primordium
(Zou et al., 1997). Constitutively active BMP receptors havea role in many important developmental processes includ-
ing establishment of the early body plan in vertebrate em- also been shown recently to transduce signals without li-
gand in a myoblast cell line (Akiyama et al., 1997).bryos (Kingsley, 1994; Hogan, 1996; Mehler et al., 1997). In
addition, BMPs have been shown to affect several aspects of Adrenergic neural crest-derived cells are characterized by
the presence of TH, the rate-limiting enzyme in the cate-neural development including the differentiation of neural
crest cells (Fann and Patterson, 1994; Graham et al., 1994; cholamine pathway (Blaschko, 1973). We were interested in
determining which type I BMP receptors were involved inVarley et al., 1995; Lein et al., 1995; Liem et al., 1995;
Paralkar et al., 1992; Varley and Maxwell, 1996; Reissmann the increase in TH-positive and catecholamine-positive cell
number observed in neural crest cultures in response to theet al., 1996; Shah et al., 1996; Gross et al., 1996). In particu-
lar, BMP-2, BMP-4, and BMP-7 have been shown to promote BMP ligands (Varley et al., 1995; Varley and Maxwell, 1996;
Reissmann et al., 1996). Accordingly we have analyzed neu-the development of tyrosine hydroxylase (TH)-positive and
catecholamine-containing cells in quail trunk neural crest ral crest cultures for the presence of mRNA for type I BMP
receptors and measured the biological response when con-cultures (Varley et al., 1995; Varley and Maxwell, 1996;
Reissmann et al., 1996). stitutively active type I BMP receptors are introduced into
cultures of quail trunk neural crest cells using a retroviralThe response of cell populations to some TGF-b super-
family members is mediated by a family of cell surface re- vector. We have found that BMPR-IA mRNA is present in
neural crest cultures and that the activated form of BMPR-ceptors with serine/threonine kinase activity (for reviews
see MassagueÂ , 1996; MassagueÂ and Weis-Garcia, 1996). IA can promote the development of increased numbers of
TH-positive and catecholamine-positive cells in neuralWhile much of our information comes from studies of the
TGF-bs themselves, some information is available concern- crest cultures. A portion of this work was presented at the
27th Annual Meeting of the Society for Neuroscience (Var-ing the BMP receptors. Current evidence indicates that the
BMP ligand is initially bound by a type II receptor in concert ley et al., 1997).
with a type I receptor (MassagueÂ , 1996; MassagueÂ and Weis-
Garcia, 1996). There is at least one BMP type II receptor
which can interact with at least three different type I BMP MATERIALS AND METHODS
receptors designated BMPR-IA (also known as ALK-3 or
BRK-1), BMPR-IB (also known as ALK-6, BRK-II, or RPK-1),
Neural crest cultures. Primary cultures of trunk neural crestand ActR-I (ten Dijke et al., 1994; Koenig et al., 1994; Liu
cells were prepared from stage 13 (Zacchei, 1961) Japanese quailet al., 1995; Nohno et al., 1995; Rosenzweig et al., 1995;
embryos (Coturnix coturnix) as described by Maxwell et al. (1982).
MassagueÂ , 1996; MassagueÂ and Weis-Garcia, 1996). The ac- In brief, neural tubes possessing the neural crest were isolated free
tivin type I receptor (ActR-I) appears to function as a recep- of surrounding somites, notochord, and ectoderm and cultured in
tor for both activin and certain BMPs (Yamashita et al., a growth medium containing 37.5 ml Dulbecco's modi®ed Eagle's
1995). medium with 4.5 g/liter glucose (Gibco-BRL), 37.5 ml F-12 (Gibco-
BRL), 15 ml horse serum (Gibco-BRL), and 10 ml of 9-day chickAfter BMP ligand is bound by the receptor, signal trans-
embryo extract (Cahn et al., 1967), 10 mg gentamicin sulfate (Scher-duction is initiated when the type II receptor phosphory-
ing), 1 ml of 0.2 M glutamine (Sigma), and 1 ml of a 1001 stocklates the type I receptor which in turn phosphorylates down-
vitamin mix. Vitamin mix stock contained 1 mg dimethyltetrahy-stream cytoplasmic proteins designated Smads (Derynck et
drobiopterin (Calbiochem), 100 mg ascorbic acid (Sigma), 10 mgal., 1996; MassagueÂ , 1996; Wrana and Attisano, 1996). The
glutathione (Sigma), and 20 ml distilled water, ®nal pH 6.0 (MainsSmads then enter the nucleus where they can act to alter
and Patterson, 1973). Cultures were grown at 37.57C in a 5% CO2patterns of gene transcription (Wrana and Attisano, 1996; atmosphere in 60-mm tissue culture dishes coated with a thin ®lm
Baker and Harland, 1996; Chen et al., 1996; Hoodless et al., of Vitrogen 100 (Collagen Corp.).
1996; Graff et al., 1996; Liu et al., 1996; Lagna et al., 1996; Secondary cultures were prepared from pooled neural crest out-
Thomsen, 1996; Zhang et al., 1996; Macias-Silva et al., growths after 42 h in vitro. Neural tubes were removed with tung-
sten needles and the cells were detached with 0.01% trypsin1996; Kretzschmar et al., 1997).
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(Gibco-BRL) in Ca2/- and Mg2/-free Dulbecco's phosphate-buffered
saline (Gibco-BRL). Trypsinization was stopped by the addition of
2 vol of growth medium. The cells were then centrifuged at 6000g
for 10 min and resuspended in growth medium at 250,000 cells per
milliliter. A 100-ml aliquot containing 25,000 cells was then plated
in 1-cm-diameter well dishes (Greiner) coated with bovine ®bro-
nectin. Cells were allowed to attach for 2 h in 100 ml of growth
medium. This initial 100 ml of medium was replaced with 5 ml of
virus at the appropriate concentration in 95 ml of fresh growth
medium. Cultures were grown in this 100 ml of medium containing
the virus for 18 h, followed by addition of 2 ml of growth medium.
Cultures were fed every other day by replacing 1 ml of growth
medium, with no additional virus added. In cases where BMP-4
(Genetics Institute, Inc.) was used it was added directly to the cul-
ture from a 10001 stock solution when cultures were fed with
FIG. 1. Type IA BMP receptors are expressed in quail neural crestgrowth medium.
cultures at 18 h. RT-PCR analysis of BMPR-IA and BMPR-IB wasIsolation and RT-PCR analysis of RNA. Total cellular RNA
performed on RNA from control (lanes 2 and 3) and BMP-4-stimu-was isolated from neural crest cultures and 4-day quail embryos
lated (lanes 4 and 5) neural crest cultures after 18 h in vitro andusing the Ultraspec RNA Isolation System (Biotecx Laboratories,
on RNA from whole day 4 embryos (lanes 6 and 7). For the PCRInc.). First-strand cDNA synthesis was primed with 0.5 mg oli-
controls (lanes 8 and 9), reverse transcriptase was omitted from ago(dT) using Superscript II reverse transcriptase (Gibco-BRL). Sam-
reaction performed on RNA from cultures grown in the absence ofples were subjected to 30 PCR cycles consisting of denaturation at
BMP-4. RT-PCR analysis of b actin was performed on RNA from947C for 2 min, annealing at 487C for 2 min, and extension at 727C
control (lane 10) and BMP-4-stimulated (lane 11) neural crest cul-for 3 min. Following PCR, reaction products were analyzed on 1.1%
tures. Lanes 1 and 12 are molecular size markers of 1353, 1078,agarose gels. Oligonucleotide primers were designed for BMPR-IA
872, and 603 bp. Lanes 2, 4, 6, and 8 are BMPR-IA; lanes 3, 5, 7,(5* sense oligo, 5*-CAAGCACTATTGTAAGTCAATG-3 *; 3 * anti-
and 9 are BMPR-IB; and lanes 10 and 11 are b actin. For BMPR-IAsense oligo, 5*-TCAAATCTTTACATCTTGTGAT-3 *), BMPR-IB
and BMPR-IB, 25 ml (neural crest cultures) or 2.5 ml (embryo) of the(5* sense oligo, 5*-TGCTACTTCAGGTATAAGCGGC-3 *; 3 * anti-
PCR products was run on a 1.1% agarose gel, while for b actin 0.5sense oligo, 5*-TTAGAGCTTAATGTCCTGCGAC-3 *), and b ac-
ml of PCR product was run.tin (5* sense oligo, 5*-TGCTGCTCACAGAGGCT-3 *; 3 * antisense
oligo, 5*-CCGGATTCATCGTACTC-3 *). For each culture condi-
tion, PCR of the type IA and IB receptors and b actin were per-
formed on aliquots of the same reverse transcriptase reaction.
culture occupied by cells with that phenotype and then calculatingRetroviral constructs. The cDNA encoding human BMPR-IA
the number of cells with that phenotype in the culture.had been subjected to site-directed mutagenesis to change Gln233
Determination of total cell number. Comparison of total cellto Asp. This mutated DNA was then cloned into a Cla12 Nco
number among different culture conditions was performed by stain-shuttle vector, excised as a Cla fragment, and cloned in the replica-
ing cultures with 4,6-diamidino-2-phenylindole (DAPI) (Sigma),tion-competent retroviral vector RCAS(A) (Hughes et al., 1987).
counting the number of nuclei per unit area using ¯uorescencePrimary chick embryo ®broblasts were transfected with the use of
microscopy, and then calculating the total number of cells in theLipofectin (Gibco-BRL). Supernatant from the transfected cultures
area of the culture occupied by cells.was collected on days 7±9 when the ®broblasts were 70±80% con-
¯uent. The viral supernatant was concentrated in Optimem (Gibco-
BRL) by ultracentrifugation and resuspended in 200 ml of Optimem,
and aliquots were stored at 0707C. The concentration of the virus RESULTS
was estimated by infection of quail trunk neural crest cultures with
serial dilutions of virus at 2 days in vitro followed 48 h later by
We wished to determine which BMP receptors were ex-staining for the viral protein p19.
pressed in neural crest cultures that are responsive to BMPs.Immunochemical and histochemical procedures. Cells that
We used reverse-transcription polymerase chain reactionwere immunoreactive for tyrosine hydroxylase were visualized by
standard indirect immuno¯uorescence using a monoclonal anti- (RT-PCR) to assay the expression of BMPR-IA and BMPR-
body to TH generously supplied by Dr. H. Hatanaka (Hatanaka and IB in neural crest cultures. Cultures were assayed after 18
Arimatsu, 1984). The viral gag encoded matrix protein, also known h in vitro to analyze the receptor population at a time when
as p19, was visualized by indirect immuno¯uorescence using the cells were known to be responsive to BMP ligands. As
monoclonal antibody 3C2 (Developmental Studies Hybridoma seen in Fig. 1, RT-PCR analysis of neural crest cultures
Bank). For double-label experiments, a rabbit antibody to TH (Pel- grown with or without BMP-4 revealed the presence of
freeze, Inc.) was used in conjunction with the monoclonal antibody
BMPR-IA transcripts. BMPR-IB transcripts were not de-to p19. Histochemical detection of catecholamine-containing cells
tected in neural crest cultures grown in either the presencewas performed using the procedure of Furness et al. (1977). The
or absence of BMP-4. Both BMPR-IA and BMPR-IB tran-microtubule-associated protein (MAP)2 was visualized using a
scripts were easily detected in samples from whole em-monoclonal antibody (Sigma). The number of TH-, p19-, and MAP2-
bryos. Technical limitations, possibly due to species differ-positive cells was determined by counting the number of cells per
unit area for three microscopic ®elds, determining the area of the ences, did not allow us to successfully assay quail ActR-I
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Keuls post hoc test. Thus, the increase in the number of
TH-positive and catecholamine-positive cells is not simply
a re¯ection of increases in total cell number, but rather the
proportion of TH-positive and catecholamine-positive cells
is increased, as observed in cultures treated with BMP-4
(Varley and Maxwell, 1996).
The morphology of the TH-positive cells in the cultures
infected with the virus encoding the caBMPR-IA was the
same as the TH-positive cells seen in wtBMPR-IA-infected
cultures or uninfected control cultures (Fig. 3). The TH-
positive cells possessed ¯uorescent cell bodies with occa-
sional ¯uorescent cellular processes. Also, the catechol-
amine-positive cells seen in the caBMPR-IA cultures were
similar to those observed under the other growth conditions
(Fig. 4).
The number of TH-positive cells which was generated
was dependent on the concentration of virus used in the
FIG. 2. Expression of caBMPR-IA increases TH and catechol- initial infection. As shown in Fig. 5, low concentrations of
amine cell number in neural crest cultures. Neural crest cultures virus resulted in fewer TH-positive cells, while the maximal
were infected with either no virus (control) or 5 1 105 IU/ml of concentration of virus, 5 1 106 IU/ml, did not increase the
virus containing either the wild-type BMPR-IA (wtBMPR-IA) or the number of TH-positive cells above that seen with 5 1 105constitutively active BMPR- IA (caBMPR-IA) construct. Cultures
IU/ml (Fig. 2).were grown for 7 days in vitro and processed to reveal TH-positive
Double-label experiments using antibodies to TH and theor catecholamine-positive cells. The number of TH-positive or cat-
viral p19 protein revealed that after 5 days in vitro, 82 {echolamine-positive cells per culture is expressed as the mean {
1% (mean { SEM, N  3) of the TH-positive cells were alsoSEM with N  8±12 cultures for each condition. The caBMPR-IA
condition is signi®cantly different from control and wtBMPR-IA p19-positive in cultures infected with virus containing the
with P  0.05 for both TH-positive and catecholamine-positive constitutively active BMPR-IA construct (Fig. 6). Thus,
cells by one-way analysis of variance with the Student±Newman± most TH-positive cells were infected with virus. There were
Keuls post hoc test. also many p19-positive cells that were TH-negative, indi-
cating that not all virally infected cells were able to differen-
tiate as TH-positive. This latter observation is consistent
with the fact that even when BMP ligand is used, only amRNA. The presence of BMPR-IA mRNA, but not BMPR-
IB mRNA, in quail trunk neural crest cultures known to fraction of the total cell population becomes TH-positive
(Varley et al., 1995; Varley and Maxwell, 1996; Reissmannrespond to the BMPs by increasing adrenergic cell develop-
ment led us to focus further attention on the BMPR-IA et al., 1996).
One important difference between previous experimentsreceptor.
A mutant BMPR-IA receptor construct with constitutive using BMP ligands (Varley et al., 1995; Varley and Maxwell,
1996; Reissmann et al., 1996) and the present experimentskinase activity (caBMPR-IA) contained in the avian replica-
tion-competent retroviral vector RCAS(A) was used in these is that it takes time for the virus to infect the cell population
and to begin to produce functional proteins, including theexperiments. The wild-type BMPR-IA construct (wtBMPR-
IA) in RCAS(A) was used as a control along with uninfected BMP receptor protein. Infection of neural crest cultures
with virus bearing the caBMPR-IA construct revealed thatcultures. Infection with a concentration of 5 1 105 IU/ml
of the viral construct coding for the caBMPR-IA resulted in after 18 h in vitro 13 { 2% (mean { SEM, N  3) of cells
expressed viral p19 protein. At 24 h in vitro, this value hadan approximately ®vefold increase in the number of both
TH-positive cells and catecholamine-positive cells per cul- risen to 38 { 2% (mean { SEM, N  3). Thus, it takes at
least a day before viral protein is expressed in a substantialture after 7 days in vitro relative to either cultures infected
with a virus containing wtBMPR-IA or cultures that were number of cells. Further analysis showed that the extent of
viral infection after 48 h, measured by p19 viral proteinnot infected with virus (Fig. 2). Total cell number was not
signi®cantly altered by infection with virus containing the expression as a function of the virus concentration, exhib-
ited a pattern similar to that seen with the development ofcaBMPR-IA construct. There were 154,012 { 10,369 (mean
{ SEM, N  6 cultures) total cells per culture when TH-positive cells at 7 days in vitro (Fig. 7). The percentage of
infected cells increased with increasing viral concentration,caBMPR-IA was used, 149,842 { 8,618 (mean { SEM, N 
6 cultures) total cells per culture when the wtBMPR-IA but plateaued at about 45% when 5 1 105 or 5 1 106 IU/
ml of caBMPR-IA-containing virus was used. The morphol-construct was used, and 123,432 { 10,675 (mean { SEM,
N 5) total cells per culture in control cultures. These total ogy of both infected and uninfected neural crest cells at 48
h after application of virus was the same (data not shown).cell values were not signi®cantly different as determined
by one-way analysis of variance and the Student±Newman± Thus, the number of cells expressing virally encoded pro-
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FIG. 3. The morphology of TH-positive cells which develop in cultures infected with virus bearing the caBMPR-IA construct is the same
as in control cultures. (A) Fluorescence photograph of TH-positive cells in neural crest cultures 7 days after infection with virus bearing
the constitutively active receptor. In all cases the TH-positive cells had ¯uorescent cell bodies and occasional ¯uorescent processes. (B)
Phase-contrast view of the same ®eld as in A. (C) Fluorescence photograph of TH-positive cells in a culture which received virus bearing
the wtBMPR-IA construct. (D) Phase-contrast view of the same ®eld as in C. (E) Fluorescence photograph of TH-positive cells in a culture
which received no virus. (F) Phase-contrast view of the same ®eld as in E. In all ®elds numerous darkly pigmented melanocytes are present
along with many cells which are neither TH-positive nor pigmented. Scale bar, 30 mm.
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FIG. 4. Catecholamine-positive cells are present in neural crest cultures infected with virus carrying the caBMPR IA construct. (A)
Fluorescence photograph of catecholamine-positive cells after 7 days in vitro. Cells have ¯uorescent cell bodies and occasional ¯uorescent
processes. (B) Phase-contrast view of the same ®eld as in A. The dark cells are pigmented melanocytes. Scale bar, 30 mm.
teins is dependent on both time after infection and the con-
centration of virus.
We wished to compare the development of TH-positive
cells in cultures grown in the presence of virus bearing the
activated receptor construct to cultures and cells grown in
the presence of the BMP ligand. Accordingly, we performed
experiments in which the addition of BMP-4 was delayed
until 18, 24, or 48 h in vitro to approximate the delayed
appearance of virally encoded protein. As seen in Fig. 8,
these experiments showed that addition of 2 ng/ml BMP-4
at 48 h resulted in about twice the number of TH-positive
cells observed with the virus bearing the caBMPR-IA con-
struct. Addition of BMP-4 at early times resulted in higher
numbers of TH-positive cells. This decline in respon-
siveness to BMP-4 addition at 48 h was not likely due to
a lack of BMPR-IA since analysis using PCR showed the
presence of BMPR-IA transcripts in cultures at 48 h in vitro
(data not shown). Thus, there is a critical period relatively
early in development in order to achieve a maximal adrener-
gic response to BMP-4 addition (see also Reissmann et al.,
1996). Our results are consistent with the notion that the
lower number of TH-positive and catecholamine-positive
cells we observed in cultures infected with the virus con-
taining the constitutively active receptor construct was
due, at least in part, to the length of time required to incor-
porate suf®cient amounts of functional receptor protein
into the cell membrane during this critical period.
We also asked if the overall temporal appearance of TH-FIG. 5. TH-positive cell number increases as a function of increas-
positive cells was altered in the presence of the retroviraling initial concentrations of virus containing the caBMPR-IA con-
construct coding for the constitutively active receptor. Asstruct. Cultures were infected with the concentration of virus indi-
shown in Fig. 9, the time course of the appearance of TH-cated as described under Materials and Methods. After 7 days in
positive cells mediated by caBMPR-IA is consistent withvitro, cultures were processed to reveal TH-positive cells. The re-
sults show a concentration-dependent increase in TH cell number that seen in control cultures, with few TH-positive cells
which plateaus starting at about 5 1 105 IU/ml. The data are ex- present at 4 days in vitro and a dramatic increase in their
pressed as the means { SEM with N  10 for each condition. number at 7 days in vitro.
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FIG. 6. Most TH-positive cells are also viral protein p19-positive when cultures are infected with virus containing the constitutively
active BMPR-IA. Neural crest cultures were grown and infected with virus as described under Materials and Methods. After 5 days in
vitro, they were processed to reveal TH-positive and viral protein p19-positive cells by a double-label protocol. (A) TH-positive cells. (B)
p19-positive cells. (C) Phase-contrast view of the same ®eld as in A and B. Note that there are many p19-positive cells that are not TH
positive, consistent with the observation from other experiments that in the presence of BMP ligands, only a subset of cells became TH
positive.
To explore the phenotypic speci®city of the effect of the
caBMPR-IA construct on neural crest development, we ex-
amined another phenotypic marker. Under our culture con-
ditions, antibody to MAP2 labels a cell population distinct
from the TH-positive cells (Maxwell and Forbes, 1990).
There was no increase in the number of MAP2-immunore-
active cells which developed in the presence of the
wtBMPR-IA, caBMPR-IA, or BMP-4 itself at 10 ng/ml (Fig.
10). The morphology of the MAP2-immunoreactive cells
was the same under all experimental conditions and was
distinct from that of TH-positive cells (Fig. 11).
DISCUSSION
In the present work we have shown that mRNA for
BMPR-IA was present in quail trunk neural crest cultures,
while mRNA for BMPR-IB was not detectable. In addition,
a constitutively active form of the BMPR-IA receptor pro-
moted the development of increased numbers of TH-posi-
tive and catecholamine-positive cells in quail trunk neural
crest cultures when introduced via a retroviral vector. The
effect was speci®c for the constitutively active form of the
receptor since the wild-type BMPR-IA did not possess this
FIG. 7. Viral infectivity increases with initial viral concentration. activity. The effect was speci®c for the adrenergic pheno-
Cultures were infected with the concentration of virus indicated type in that MAP2-immunoreactive cells were unaffected.
as described under Materials and Methods. After 48 h in vitro, The increased numbers of TH-positive and catecholamine-
cultures were processed to reveal viral p19 protein by indirect im-
positive cells which developed were morphologically indis-muno¯uorescence. The results show that there is a concentration-
tinguishable from those either in control cultures or in cul-dependent increase in the number of virally infected cells with a
tures where the TH-positive cell or catecholamine-positiveplateau at about 45% of cells infected starting at about 5 1 105 IU/
cell number was increased by the presence of appropriateml. The data are expressed as the means{ SEM with N 3 cultures
for each condition. BMP ligands.
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thetic trunks (Reissmann et al., 1996). Similarly, in the
mouse and the rat, mRNA for BMP-2, BMP-4, and BMP-7 is
present at sites near where neural crest-derived sympathetic
neurons develop (Bitgood and McMahon, 1995; Lyons et al.,
1995; Shah et al., 1996). During avian development, the
neural crest cells which form the sympathetic trunk ini-
tially coalesce at sites immediately adjacent to the dorsal
aorta. Thus, neural crest cells are in very close proximity
to the source of BMP ligand at the stages when they ®rst
express the adrenergic phenotype.
Our ®nding that expression of activated BMPR-IA is able
to increase the number of TH-positive cells which develop
in neural crest cultures has important implications for un-
derstanding neural crest differentiation. Our results indi-
cate that activation of BMPR-IA in some neural crest cells
grown in medium containing serum and embryo extract is
capable of triggering the downstream events in the pathway
required for expression of the adrenergic phenotype. Our
present results do not allow us to conclude whether the
FIG. 8. Delayed addition of BMP-4 decreases the number of TH- activated receptor promotes an increased probability of dif-positive cells per culture which develop. Neural crest cultures were
ferentiation, increased survival, or increased proliferationprepared as described under Materials and Methods. BMP-4 (2 ng/
in a population of adrenergic precursors. However, previousml) was added at the times indicated and the cultures were assayed
analyses of the action of BMP ligands favor the interpreta-for the number of TH-positive cells after 7 days in vitro. The results
show that a delay of 48 h prior to addition of 2 ng/ml of BMP-4
resulted in numbers of TH-positive cells per culture which are in
the same range as experiments using virus bearing the activated
receptor construct. The results are expressed as the means { SEM
with N  6 for each condition. The 48-h condition is signi®cantly
different from the other conditions with P 0.05 by one-way analy-
sis of variance and the Student±Newman±Keuls post hoc test.
In the embryo, neural crest cells that will give rise to
the adrenergic neurons of the sympathetic ganglia migrate
ventrally from their initial position on the dorsal neural
tube to sites lateral to the dorsal aorta, where they cease
migration and coalesce to form the nascent sympathetic
trunks (Weston, 1970). The ®rst evidence of differentiation
of both adrenergic traits and neural transcription factors in
this cell population occurs after the cessation of migration
in a location adjacent to the dorsal aorta (Enemar et al.,
1965; Allan and Newgreen, 1977; Cochard et al., 1978;
Teitelman et al., 1979; Groves et al., 1995; Ernsberger et al.,
1995). These ®ndings, along with transplantation studies,
indicate that cues in the local microenvironment are ex-
tremely important in¯uences on neural crest development
in vivo (Noden, 1978; LeDouarin, 1982). Data from in vitro
studies have identi®ed the BMPs as leading candidates for
FIG. 9. The temporal appearance of TH-positive cells after infec-some of the environmental in¯uences in neural crest differ-
tion with virus bearing the caBMPR-IA construct. Neural crestentiation (Graham et al., 1994; Varley et al., 1995; Varley
cultures were prepared as described under Materials and Methodsand Maxwell, 1996; Reissmann et al., 1996; Shah et al.,
and cultures were infected with either no virus (control) or 5 1 1051996).
IU/ml or virus bearing the wtBMPR-IA or the caBMPR-IA con-
Recent evidence has shown that BMP mRNA is present struct. The results show that the time course of appearance of TH-
at sites where neural crest cells cease migration and begin positive cells is similar in all cases, with few TH-positive cells
to differentiate. In avian embryos, mRNA for BMP-4 and present at 4 days in vitro and increased number present after 7 days
BMP-7 is made by the dorsal aorta at stages when neural in vitro. Values are expresses as the means { SEM, with N  6 for
each condition.crest cells begin to condense to form the primary sympa-
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tivity following transfection of activated mutations of type
I receptors for TGF-b, activin, and BMP into cell lines,
rather than cells cultured directly from the embryo (Wieser
et al., 1995; Attisano et al., 1996; Hoodless et al., 1996).
Reporter activity in these systems was between 5 and 20
times the basal activity level, depending on the amount of
activated receptor DNA that was used in the transfection.
Thus, the ®vefold increase we observed in neural crest cul-
tures was within the range of these experiments.
Some of the biological constraints on the viral life cycle
are likely a major reason for the smaller number of TH-
positive cells observed with the caBMPR-IA construct com-
pared to maximal doses of BMP-4 added at time zero. To
have functional caBMPR-IA in the neural crest cell mem-
brane, the virus must bind to cell surface and then undergo
FIG. 10. The number of MAP2-positive cells per culture is not
appropriate integration, transcription, splicing, translation,altered by the activated BMP receptor or BMP-4 ligand. Neural crest
and insertion of active caBMPR-IA protein into the neuralcultures were prepared and treated as described under Materials
crest cell membrane. Limitations in more than one of theseand Methods with either no virus (control) or 5 1 105IU/ml of virus
steps will have compounding effects. Our data on the pat-bearing the wtBMPR-IA or caBMPR-IA construct or 10 ng/ml of
tern of viral infectivity are consistent with either limitingBMP-4 in the absence of virus. The results show no change in
receptors on the cell surface or limiting postreceptor eventsthe number of MAP2-immunoreactive cells per culture among the
treatment groups after 7 days in vitro. Values are expressed as (Homburger and Fekete, 1996; Fekete and Cepko, 1993).
means { SEM with N  4 for each condition. Since it takes 24±48 h for virally infected cells to express
signi®cant amounts of viral protein, it is appropriate to
compare the effects of the caBMPR-IA construct to the ef-
fects of delayed BMP-4 addition. Our experiments showed
tion that they act by an instructive mechanism to increase a reduction in the number of TH-positive cells after delayed
the probability of differentiation (Varley et al., 1996; Reiss- addition of BMP-4. These results on the effect of delayed
mann et al., 1996; Shah et al., 1996). In addition, our ®nding BMP-4 addition agree with those of Reissmann et al. (1996).
that most TH-positive cells are infected with virus bearing Our data are consistent with the idea that the magnitude
the caBMPR-IA construct supports the view that the adren- of the response to the virally encoded caBMPR-IA may be
ergic phenotype is being induced directly by BMP signaling, governed by the time delay required to accumulate suf®-
rather than indirectly via another factor produced by cells cient caBMPR-IA in neural crest cell membrane. This delay
that receive a BMP signal. may be long enough that by the time there is suf®cient
In the present experiments the observed increase in TH- caBMPR-IA protein in the neural crest cell membrane, the
positive and catecholamine-positive cell number was about developmental ability of the cell to respond to the signal
transduced by this receptor may be attenuated.®vefold. Previous studies have examined reporter gene ac-
FIG. 11. The morphology of MAP2-immunoreactive cells. (A) MAP2-immunoreactive cells in a control culture. (B) Phase-contrast view
of the same ®eld as in A. The MAP2 cells appeared the same under all experimental conditions shown in Fig. 10. Scale bar, 10 mm.
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